XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.8.0.1

EMPLOYEE BENEFIT PLANS | 3 Months Ended
--- | ---
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
EMPLOYEE BENEFIT PLANS | EMPLOYEE BENEFIT PLANS Stock-Based Compensation Plans. The following table summarizes stock options and stock appreciation rights activity during the First Quarter:
Stock Options and Stock Appreciation Rights |  | Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Aggregate Intrinsic Value
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands)
Outstanding at December 30, 2017 |  | 2,177 |  |  | $ | 50.01 |  |  | 5.3 |  | $ | — |
Granted |  | — |  |  | — |  |  |  |  | — |
Exercised |  | — |  |  | — |  |  |  |  | — |
Forfeited or expired |  | (100 | ) |  | 47.39 |  |  |  |  | — |
Outstanding at March 31, 2018 |  | 2,077 |  |  | 50.14 |  |  | 2.0 |  | — |
Exercisable at March 31, 2018 |  | 1,483 |  |  | $ | 55.23 |  |  | 2.1 |  | $ | — |
The aggregate intrinsic value shown in the table above is before income taxes and is based on (i) the exercise price for outstanding and exercisable options/rights at March 31, 2018 and (ii) the fair market value of the Company’s common stock on the exercise date for options/rights that were exercised during the First Quarter. Stock Options and Stock Appreciation Rights Outstanding and Exercisable. The following tables summarize information with respect to stock options and stock appreciation rights outstanding and exercisable at March 31, 2018:
Cash Stock Appreciation Rights Outstanding |  | Cash Stock Appreciation Rights Exercisable
Range of Exercise Prices |  | Number of Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Number of Shares |  | Weighted- Average Exercise Price
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands) |  |
$29.78 - $47.99 |  | 61 |  |  | $ | 36.73 |  |  | 1.0 |  | 38 |  |  | $ | 36.73 |
Total |  | 61 |  |  | $ | 36.73 |  |  | 1.0 |  | 38 |  |  | $ | 36.73 |
Stock Options Outstanding |  | Stock Options Exercisable
Range of Exercise Prices |  | Number of Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Number of Shares |  | Weighted- Average Exercise Price
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands) |  |
$13.65 - $29.49 |  | 35 |  |  | $ | 14.12 |  |  | 0.9 |  | 35 |  |  | $ | 14.12 |
$29.78 - $47.99 |  | 43 |  |  | 38.40 |  |  | 1.8 |  | 43 |  |  | 38.40 |
$55.04 - $83.83 |  | 87 |  |  | 81.35 |  |  | 2.7 |  | 87 |  |  | 81.35 |
$95.91 - $131.46 |  | 124 |  |  | 127.98 |  |  | 3.6 |  | 124 |  |  | 127.98 |
Total |  | 289 |  |  | $ | 86.74 |  |  | 2.7 |  | 289 |  |  | $ | 86.74 |
Stock Appreciation Rights Outstanding |  | Stock Appreciation Rights Exercisable
Range of Exercise Prices |  | Number of Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Number of Shares |  | Weighted- Average Exercise Price
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands) |  |
$13.65 - $29.49 |  | 66 |  |  | $ | 29.49 |  |  | 4.7 |  | 34 |  |  | $ | 29.49 |
$29.78 - $47.99 |  | 1,452 |  |  | 38.01 |  |  | 1.6 |  | 916 |  |  | 38.14 |
$55.04 - $83.83 |  | 124 |  |  | 79.15 |  |  | 3.8 |  | 120 |  |  | 79.62 |
$95.91 - $131.46 |  | 85 |  |  | 115.60 |  |  | 3.2 |  | 86 |  |  | 115.60 |
Total |  | 1,727 |  |  | $ | 44.48 |  |  | 2.0 |  | 1,156 |  |  | $ | 47.94 |
Restricted Stock, Restricted Stock Units and Performance Restricted Stock Units. The following table summarizes restricted stock, restricted stock unit and performance restricted stock unit activity during the First Quarter:
Restricted Stock, Restricted Stock Units and Performance Restricted Stock Units |  | Number of Shares |  | Weighted-Average Grant Date Fair Value Per Share
|  | (in Thousands) |  |
Nonvested at December 30, 2017 |  | 2,981 |  |  | $ | 20.84 |
Granted |  | 233 |  |  | 9.03 |
Vested |  | (329 | ) |  | 39.62 |
Forfeited |  | (201 | ) |  | 23.07 |
Nonvested at March 31, 2018 |  | 2,684 |  |  | $ | 17.33 |
The total fair value of restricted stock and restricted stock units vested during the First Quarter was approximately $4.2 million. Vesting of performance restricted stock units is based on achievement of sales growth and operating margin targets in relation to the performance of a certain identified peer group.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration